Skip to content

Clinical trials

Phase 1/2 Leukemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 1/2 Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20153
20168
20173
20181
20194
20212
20233
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status20
Completed3
Recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Southwest Hospital, China6
Chongqing Precision Biotech Co., Ltd5
Beijing Immunochina Medical Science & Technology Co., Ltd.2
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China1
Affiliated Hospital to Academy of Military Medical Sciences1
AstraZeneca1
Bristol-Myers Squibb1
Essen Biotech1
Hebei Senlang Biotechnology Inc., Ltd.1
Maxinovel Pty., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia27
Lymphoma12
Leukemia, B-Cell4
Leukemia, Myeloid, Acute4
Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid2
Lymphoma, B-Cell2
Multiple Myeloma2
Anemia1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.